Carlos Zambrano will stay in the bullpen for now

6 Comments

Now that the Cubs’ starters are struggling as much as their relievers Lou Piniella was asked yesterday whether he’s considered moving Carlos Zambrano back into the rotation:

No, right now we need Carlos right where he’s at. We asked Carlos to do something that would help this team, and it’s helped this team. If you don’t hold onto leads late in the game, it has a lasting effect on the team.

Which is funny, because a) if you don’t have any late leads to protect that also has a lasting effect on the team, and b) Zambrano hasn’t exactly pitched brilliantly out of the bullpen. Zambrano has allowed three runs in six innings as a reliever, with opponents batting .346 against him. He’s also allowed three of his six inherited runners score, which while not reflected in ERA is certainly a big part of relief value.
He’s been decent as a reliever so far, but no one moves a pitcher making $18 million to the bullpen just so he can be decent and Zambrano has thrown just six innings in a 17-day stretch when he would have started three times. All of which is why it was silly to take a perfectly good starting pitcher capable of logging 200-plus innings and move him into a 70-inning role.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.